FAP: IBMX/rosiglitazone

Pathway ID: SIGNOR-FapIBMXR

Description: IBMX is an inhibitor of phosphodiesterases that stimulates adipogenesis while rosiglitazone is a PPARg selective agonist.

Curated by: gcesareni

12 Seed Entities

Organism:
Name Primary ID
PRKACA P17612
PDE1C Q14123
3',5'-cyclic AMP CHEBI:17489
CREB1 P16220
rosiglitazone CHEBI:50122
PPARG P37231
ADCY1 Q08828
3-isobutyl-1-methyl-7H-xanthine CHEBI:34795
Adipogenesis SIGNOR-PH26
CEBPB P17676
PDE1B Q01064
PDE1A P54750